- Home
- MSW vs XTNT Comparison
MSW vs XTNT Comparison
Compare MSW & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSW
- XTNT
- Stock Information
- Founded
- MSW 2012
- XTNT N/A
- Country
- MSW Hong Kong
- XTNT United States
- Employees
- MSW N/A
- XTNT N/A
- Industry
- MSW
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSW
- XTNT Health Care
- Exchange
- MSW NYSE
- XTNT Nasdaq
- Market Cap
- MSW N/A
- XTNT 60.9M
- IPO Year
- MSW 2024
- XTNT N/A
- Fundamental
- Price
- MSW $3.59
- XTNT $0.50
- Analyst Decision
- MSW
- XTNT Strong Buy
- Analyst Count
- MSW 0
- XTNT 1
- Target Price
- MSW N/A
- XTNT $3.00
- AVG Volume (30 Days)
- MSW 64.5K
- XTNT 40.5K
- Earning Date
- MSW 05-25-2025
- XTNT 03-06-2025
- Dividend Yield
- MSW N/A
- XTNT N/A
- EPS Growth
- MSW 18.78
- XTNT N/A
- EPS
- MSW 0.20
- XTNT N/A
- Revenue
- MSW $31,769,612.00
- XTNT $117,267,000.00
- Revenue This Year
- MSW N/A
- XTNT $15.56
- Revenue Next Year
- MSW N/A
- XTNT $22.39
- P/E Ratio
- MSW $17.66
- XTNT N/A
- Revenue Growth
- MSW 30.91
- XTNT 28.44
- 52 Week Low
- MSW $2.12
- XTNT $0.33
- 52 Week High
- MSW $10.58
- XTNT $1.18
- Technical
- Relative Strength Index (RSI)
- MSW N/A
- XTNT 50.16
- Support Level
- MSW N/A
- XTNT $0.45
- Resistance Level
- MSW N/A
- XTNT $0.54
- Average True Range (ATR)
- MSW 0.00
- XTNT 0.05
- MACD
- MSW 0.00
- XTNT 0.00
- Stochastic Oscillator
- MSW 0.00
- XTNT 63.64
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.